Belkin Vision receives 17.5 million euros to support glaucoma laser development
Click Here to Manage Email Alerts
Belkin Vision has been selected to receive 17.5 million euros in grants and equity from the European Innovation Council Accelerator to aid in the development of its glaucoma laser, according to a company press release.
More than 2,000 companies applied for the funding, and Belkin Vision was one of 99 to receive a portion of the 627 million euros in available funds. The funding “will be used to begin commercialization and to scale up the company ... at a significantly higher rate, initially in Europe and then globally in order to bring accessible glaucoma care to all,” according to the release.
“We couldn’t be happier to be selected to receive EIC funding,” Daria Lemann Blumenthal, CEO of Belkin Vision, said in the release. “This validation from the EU will help us to continue to drive our technology forward, allowing us to bring to market a treatment for glaucoma which will significantly impact population health and the prevention of blindness worldwide.”